Opus Genetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Opus Genetics and other ETFs, options, and stocks.About IRD
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
CEOGeorge Magrath
CEOGeorge Magrath
Employees18
Employees18
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2018
Founded2018
Employees18
Employees18
IRD Key Statistics
Market cap162.07M
Market cap162.07M
Price-Earnings ratio-1.37
Price-Earnings ratio-1.37
Dividend yield—
Dividend yield—
Average volume787.93K
Average volume787.93K
High today$2.51
High today$2.51
Low today$2.32
Low today$2.32
Open price$2.43
Open price$2.43
Volume334.58K
Volume334.58K
52 Week high$2.59
52 Week high$2.59
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
As of today, Opus Genetics(IRD) shares are valued at $2.36. The company's market cap stands at 162.07M, with a P/E ratio of -1.37.
During the trading session on 2025-12-13, Opus Genetics(IRD) shares reached a daily high of $2.51 and a low of $2.32. At a current price of $2.36, the stock is +1.7% higher than the low and still -6.0% under the high.
Trading activity shows a volume of 334.58K, compared to an average daily volume of 787.93K.
The stock's 52-week range extends from a low of $0.65 to a high of $2.59.
The stock's 52-week range extends from a low of $0.65 to a high of $2.59.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IRD. This list is generated using Robinhood data, and it’s not a recommendation.